Issue
Korean Journal of Chemical Engineering,
Vol.23, No.2, 241-246, 2006
Studies on cultivation and biological activities of Pleurotus nebrodensis inzenga
Environmental factors affecting mycelial growth and exo-polysaccharide production from Pleurotus nebroden-sis Inzenga (PN) and biological activities of PN extracts in vitro were studied. The culture conditions for effective my-celial growth and exo-polysaccharide production were found to be 25oC, 5% of inoculum size, and an initial pH from6.5 to 7.0. When 5% of glucose was used, the maximum mycelial growth and exo-polysaccharide concentrations were8.3 and 3.07g/L, respectively. Among the various nitrogen sources, the mycelial growth and exo-polysaccharide pro-duction were very strong when polypeptone was used. In the case of the minerals sources, K2HPO4 and MgSO4·7H2Owere found to best support for mycelial growth and exo-polysaccharide production. Under optimal conditions and meth-ods, the maximum mycelial growth and exo-polysaccharide production were obtained after 10 days of culture, 12.84and 4.85g/L, respectively, in a jar fermentor. The effects of the PN extracts on the viability of three human cancer celllines and antioxidant activity were investigated in vitro. When cancer cells of the lung (A549), cervical region (HeLa)and colon (KM12C) were incubated at 6 mg/mL of the PN ethanol extracts, the viabilities of the HeLa and KM12Ccells were slightly decreased. However, the growth of the A549 cells was remarkably inhibited when the PN ethanolextract was over 4mg/mL. The antioxidant activity showed 46.2% at 40μL, which was about 3.2 fold higher thanthat of the PN methanol extract.
[References]
  1. Bae JT, Sinha J, Park JP, Song CH, Yun JW, J. Microbiol. Biotechnol., 10, 482, 2000
  2. Bobek P, Galbavy S, J. Biomed. Sci., 58, 164, 2001
  3. Cha WS, Choi DB, Kang SH, Biotech. Biopro. Bioeng., 9, 369, 2004
  4. Chi JH, Ha TM, Kim YH, Rho YD, Korean J. Mycol., 24, 214, 1996
  5. Choi DB, Kang SH, Song YH, Kwun KH, Jeong KJ, Cha WS, J. Microbiol. Biotechnol., 15, 368, 2005
  6. Hashimoto K, Takahashi Z, Mush. Sci., 9, 585, 1974
  7. Halliwell B, Gutteridge JMC, Biochem. J., 219, 1, 1984
  8. Hong IP, Lee MW, Kor. J. Mycol., 18, 42, 1990
  9. Hong JS, Choi YH, Yun SE, Kor. J. Mycol., 14, 121, 1986
  10. Huang N, Colored illustrations of macrofungi mushrooms of China, China Agricultural Press, Beijing, pp. 23-29, 1998
  11. Jung IC, Kim SH, Kwon YI, Kim SY, Lee JS, Park S, Park KS, Lee JS, Kor. J. Mycol., 25, 133, 1997
  12. Kim HH, Na JG, Chang YK, Chun GT, Lee SJ, Jeong YH, J. Microbiol. Biotechnol., 14(5), 944, 2004
  13. Kim HK, Park JS, Cha DY, Kim YS, Moon BJ, Kor. J. Mycol., 22, 145, 1994
  14. Noda S, “Antibiotic fungicide extracted from Basidiomycetes culture (e.g. Shitake, Flammulina velutips, Polyporus, Pleurotus, etc.),” J P Patent 8445268, 1998
  15. Noda S, “Preparation of an antiviral agent by deep culture Basidiomycetes,” J P Patent 83162084, 1998
  16. Noda S, “A preparation for kindey treatment possessing antiflammatory activity, obtained from Basidiomycetes, e.g. Lentinus, Pleurotus, Flammulina, and Tricholoma,” J P Patent 8511888, 1998
  17. Oguri S, Ando A, Nagata Y, J. Bacteriol., 178, 5692, 1996
  18. Ohga S, J. Wood Sci., 45, 431, 1999
  19. Opletal L, Jahodar L, Chabot V, Zdansky P, Lukes J, Bratova M, Solichova D, Blunden G, Dacke CG, Patel A, Br. Biomed. Sci., 54, 240, 1997
  20. Park KS, Park S, Jung IC, Ha HC, Kim SH, Lee JS, Kr. J. Myco, 22, 184, 1994
  21. Paulik S, Svreck S, Mojzisova J, Durove A, Benishek Z, Huska M, Zentrabl Vecterinaermed Reihe B., 43, 129, 1996
  22. Yang FC, Liau CB, Process Biochem., 33(5), 547, 1998
  23. Yang FC, Ke YF, Kuo SS, Enzyme Microb. Technol., 27(3-5), 295, 2000
  24. Zadrazil F, Mushroom Sci., 9, 621, 1974